Minimally invasive biopsy enables real-time tracking of amyloid disease progression

Transthyretin amyloidosis (ATTR) is a rare, progressive and highly aggressive degenerative disease. It is caused by the misfolding of a specific protein, leading to its toxic accumulation in the form of filamentous deposits in various organs. Researchers at the University of Geneva (UNIGE), in collaboration with the Università della Svizzera Italiana (USI), have succeeded for … Read more

Dual treatment strategy offers survival advantage for patients with severe heart disease

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is associated with a high risk of death. Until now, treatment has consisted of valve replacement, while the deposits in the heart muscle, known as amyloidosis, often remain untreated. An international research consortium led by MedUni Vienna … Read more

Sold-out Amyloidosis conference to shine spotlight on breakthroughs, challenges and supports

Featured photo: Rosaline Callaghan and James Green of ATTR Amyloidosis All Ireland Support Group at the 2022 amyloidosis conference. Photo: Clive Wasson. A major conference on Amyloidosis will bring a global audience to Derry next month to delve into the rare condition. The event, taking place from 13-15th of June, received significant interest from healthcare … Read more

FDA Approves Vutrisiran RNA: A Breakthrough Treatment

Hope is on the horizon for those battling transthyretin amyloid cardiomyopathy (ATR-CM). The recent FDA approval of vutrisiran provides a groundbreaking new treatment option, offering a targeted approach to improve cardiovascular outcomes for individuals living with this challenging condition.Learn how this innovative RNA interference therapy works to combat ATR-CM and why it represents a meaningful … Read more

Amyloidosis: Understanding the Disease That Affected Him

oliviero ⁣Toscani’s⁤ Battle with ‍Amyloidosis: A Rare Disease That Took His Life He knew ⁤his illness was serious. He knew⁤ he​ didn’t ⁤have much time. Oliviero⁣ toscani, the renowned photographer who passed away on‌ January 13⁢ at ⁤the ‌age ⁢of​ 82, had been battling amyloidosis. In a candid interview with⁤ Corriere della Sera, he​ revealed … Read more

suffers from amyloidosis, an incurable disease

Archyde Oliviero ⁢Toscani⁤ Hospitalized: A⁤ Look at His Health‌ Battle Table of Contents 1. Oliviero ⁢Toscani⁤ Hospitalized: A⁤ Look at His Health‌ Battle 2. The Struggle with Amyloidosis 3. Who is Oliviero Toscani? 4. The Impact of His Illness 5. Looking ⁢Ahead 6. Understanding Amyloidosis: ⁤A Rare⁣ Disease with⁤ Serious Implications 7. what is amyloidosis? … Read more